Biodegradable nanoparticles for oral delivery of peptides: Is there a role for polymers to affect mucosal uptake?

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 50, Issue 1, 2000, Pages 147-160

  Jung, T ^a   Kamm, W ^a,b   Breitenbach, A ^a   Kaiserling, E ^c   Xiao, J X ^c   Kissel, T ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Biodegradable polyester; Intestinal absorption; Mucosal vaccination; Nanoparticle

Indexed keywords

DRUG CARRIER; NANOPARTICLE; PEPTIDE; POLYGLACTIN; POLYMER; POLYSTYRENE;

ANIMAL EXPERIMENT; DRUG DELIVERY SYSTEM; ENCAPSULATION; GASTROINTESTINAL ABSORPTION; INTESTINE ABSORPTION; INTESTINE MUCOSA; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PHYSICAL CHEMISTRY; REVIEW; SURFACE CHARGE; VACCINATION;

ADMINISTRATION, ORAL; ANIMALS; BIODEGRADATION, ENVIRONMENTAL; DRUG CARRIERS; EXCIPIENTS; HUMANS; MICROSPHERES; MUCOUS MEMBRANE; PEPTIDES; POLYMERS;

EID: 0034601281     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(00)00084-9     Document Type: Review

References (92)

1. Damgé C., Michel C., Aprahamian M., Couvreur P., Devissaguet J.P. Nanocapsules as carrier for oral peptide delivery. J. Control. Release. 13:1990;233-239.
2. Brandtzaeg P., Berstad A.E., Farstad I.N., Haraldsen G., Helgeland L., Jahnsen F.L., Johansen F.E., Natvig I.B., Nilsen E.M., Rugtveit J. Mucosal immunity - a major adaptive defense mechanism. Behring Inst. Mitt. 98:1997;1-23.
3. Lee V.H., Yamamoto A. Penetration and enzymatic barriers to peptide and protein absorption. Adv. Drug Deliv. Rev. 4:1990;171-207.
4. Florence A.T. The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm. Res. 14:1997;259-266.
5. Neutra M.R., Pringault E., Kraehenbuhl J.P. Antigen sampling across epithelial barriers and induction of mucosal immune responses. Annu. Rev. Immunol. 14:1996;275-300.
6. Sanderson I.R., Walker W.A. Uptake and transport of macromolecules by the intestine: possible role in clinical disorders (an update). Gastroenterology. 104:1993;622-639.
7. Gebert A., Rothkotter H.J., Pabst R. cells in Peyer's patches of the intestine. Int. Rev. Cytol. 167:1996;91-159.
8. Jani P., Halbert G.W., Langridge J., Florence T. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J. Pharm. Pharmacol. 41:1989;809-812.
9. Volkheimer G., Schulz F.H. The phenomenon of persorption. Digestion. 1:1968;213-218.
10. Volkheimer G. Persorption von Mikropartikeln. Pathologe. 14:1993;247-252.
11. Schipper N.G., Olsson S., Hoogstraate J.A., de Boer A.G., Varum K.M., Artursson P. Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement. Pharm. Res. 14:1997;923-929.
12. Lehr C.M., Bouwstra J.A., Tukker J.J., Junginger H.E. Intestinal transit of bioadhesive microspheres in an in situ loop in the rat-a comparative study with copolymer and blends on poly(acrylic acid). J. Control. Release. 13:1990;51-62.
13. Kriwet B., Kissel T. Poly (acrylic acid) Microparticles widen the intercellular spaces of Caco-2 cell monolayers: An examination by confocal laser scanning microscopy. Eur. J. Pharm. Biopharm. 42:1996;233-240.
14. Bjork E., Isaksson U., Edman P., Artursson P. Starch microspheres induce pulsatile delivery of drugs and peptides across the epithelial barrier by reversible separation of the tight junctions. J. Drug Targeting. 2:1995;501-507.
15. Volkheimer G. Persorption of particles: physiology and pharmacology. Adv. Pharmacol. Chemother. 14:1977;163-187.
16. Mellman I. Endocytosis and molecular sorting. Annu. Rev. Cell Dev. Biol. 12:1996;575-625.
17. Okamoto C.T. Endocytosis and transcytosis. Adv. Drug Deliv. Rev. 29:1998;215-228.
18. Swaan P.W. Recent advances in intestinal macromolecular drug delivery via receptor-mediated transport pathways. Pharm. Res. 15:1998;826-834.
19. Lehr C.M. The transcytosis approach. De Boer A.G. Drug Absorption Enhancement - Concepts, Possibilities, Limitations and Trends. 1994;Harwood Academic, Chur, Switzerland.
20. Holmgren J., Capron P.B.P.A., Francotte M., Kilian M., Kraehenbuhl J.P., Lehner T., Seljelid R. European Commission COST/STD Initiative. Report of the expert panel VI. Concerted efforts in the field of mucosal immunology. Vaccine. 14:1996;644-664.
21. Husband A.J. Novel vaccination strategies for the control of mucosal infection. Vaccine. 11:1993;107-112.
22. Brandtzaeg P., Farstad I.N., Haraldsen G., Jahnsen F.L. Cellular and molecular mechanisms for induction of mucosal immunity. Dev. Biol. Stand. 92:1998;93-108.
23. Ebel J.P. A method for quantifying particle absorption from the small intestine of the mouse. Pharm. Res. 7:1990;848-851.
24. Pappo J., Ermak T.H. Uptake and translocation of fluorescent latex particles by rabbit Peyer's patch follicle epithelium: a quantitative model for M cell uptake. Clin. Exp. Immunol. 76:1989;144-148.
25. Scherer D., Mooren F.C., Kinne R.K., Kreuter J. In vitro permeability of PBCA nanoparticles through porcine small intestine. J. Drug Targeting. 1:1993;21-27.
26. Delie F. Evaluation of nano- and microparticle uptake by the gastrointestinal tract. Adv. Drug Deliv. Rev. 34:1998;221-233.
27. Norris D.A., Sinko P.J. Effect of size, surface charge, and hydrophobicity on the translocation of Polystyrene microspheres through gastrointestinal mucin. J. Appl. Polym. Sci. 63:1997;1481-1492.
28. Jani P.U., Halbert G.W., Langridge J., Florence A.T. Nanoparticle uptake by the rat gastrointestinal mucosa: Quantitation and particle size dependency. J. Pharm. Pharmacol. 42:1990;821-826.
29. Nwokolo C.U., Lewin J.F., Hudson M., Pounder T.R. Transmucosal penetration of bismuth particles in the human stomach. Gastroenterology. 102:1992;163-167.
30. LeFevre M.E., Boccio A.M., Joel D.D. Intestinal uptake of fluorescent microspheres in young and aged mice. Proc. Soc. Exp. Biol. Med. 190:1989;23-27.
31. Seifert J., Haraszti B., Sass W. The influence of age and particle number on absorption of polystyrene particles from the rat gut. J. Anat. 189:1996;483-486.
32. 14C-poly(D,L-lactic acid) nanoparticles coated with human serum albumin or polyvinyl alcohol to guinea pigs. J. Drug Targeting. 6:1998;293-307.
33. Alpar H.O., Field W.N., Hyde R., Lewis D.A. The transport of microspheres from the gastro-intestinal tract to inflammatory air pouches in the rat. J. Pharm. Pharmacol. 41:1989;194-196.
34. Lazorova L., Artursson P., Engström A., Sjölander A. Transport of an influenza virus vaccine formulation (iscom) in Caco-2 cells. Am. J. Physiol. 270:1996;554-564.
35. Bomsel M. transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat. Med. 3:1997;42-47.
36. Frey A., Giannasca K.T., Weltzin R., Giannasca P.J., Reggio H., Lencer W.I., Neutra M.R. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J. Exp. Med. 184:1996;1045-1059.
37. Hillery A.M., Toth I., Shaw A.J., Florence A.T. Co-polymerized peptide particles (CPP) I: synthesis, characterization and in vitro studies on a novel oral nanoparticulate delivery system. J. Control. Release. 41:1996;271-281.
38. Desai M.P., Labhasetwar V., Walter E., Levy R.J., Amidon G.L. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm. Res. 14:1997;1568-1573.
39. McClean S., Prosser E., Meehan E., Malley D.O., Clarke N., Ramtoola Z., Brayden D. Binding and uptake of biodegradable poly-DL-lactide micro- and nanoparticles in intestinal epithelia. Eur. J. Pharm. Sci. 6:1998;153-163.
40. Kerneis S., Bogdanova A., Kraehenbuhl J.P., Pringault E. Conversion by Peyer's patch lymphocytes of human enterocytes into M Cells that transport bacteria. Science. 277:1997;949-952.
41. Deshmukh D.S., Bear W.D., Brockerhoff H. Can intact liposomes be absorbed in the gut? Life Sci. 28:1981;239-242.
42. Sjolander A., Cox J.C. Uptake and adjuvant activity of orally delivered saponin and ISCOM vaccines. Adv. Drug Deliv. Rev. 34:1998;321-338.
43. Andrianov A.K., Payne L.G. Polymeric carriers for oral uptake of microparticulates. Adv. Drug Deliv. Rev. 34:1998;155-170.
44. Kreuter J. Peroral administration of nanoparticles. Adv. Drug Deliv. Rev. 7:1991;71-86.
45. Birrenbach G., Speiser P. Polymerized micelles and their use as adjuvants in immunology. J. Pharm. Sci. 65:1976;1763-1766.
46. Allémann E., Gurny R., Doelker E. Drug loaded nanoparticles-preparation methods and drug targeting issues. Eur. J. Pharm. Biopharm. 39:1993;173-191.
47. Quintanar-Guerrero D., Allémann E., Fessi H., Doelker E. Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev. Ind. Pharm. 24:1998;1113-1128.
48. Haltner E., Easson J.H., Lehr C.M. Lectins and bacterial invasion factors for controlling endo- and transcytosis of bioadhesive drug carrier systems. Eur. J. Pharm. Biopharm. 44:1997;3-13.
49. Carreno-Gomez B., Woodley J.F., Florence A.T. Studies on the uptake of tomato lectin nanoparticles in everted gut sacs. Int. J. Pharm. 183:1999;7-11.
50. Russell-Jones G.J. The potential use of receptor-mediated endocytosis for oral drug delivery. Adv. Drug Deliv. Rev. 20:1996;83-97.
51. Lehr C.M., Lee V.H. Binding and transport of some bioadhesive plant lectins across Caco-2 cell monolayers. Pharm. Res. 10:1993;1796-1799.
52. Hussain N., Jani P.U., Florence A.T. Enhanced oral uptake of tomato lectin-conjugated nanoparticles in the rat. Pharm. Res. 14:1997;613-618.
53. Irache J.M., Durrer C., Duchene D., Ponchel G. Bioadhesion of lectin-latex conjugates to rat intestinal mucosa. Pharm. Res. 13:1996;1716-1719.
54. Jepson M.A., Mason C.M., Clark M.A., Simmons N.L., Hirst B.H. Variations in lectin binding properties of intestinal M cells. J. Drug Targeting. 3:1995;75-77.
55. Hart C.A., Batt R.M., Saunders J.R., Getty B. Lectin-induced damage to the enterocyte brush border. An electron-microscopic study in rabbits. Scand. J. Gastroenterol. 23:1988;1153-1159.
56. Russell-Jones G.J., Arthur L., Walker H. Vitamin B12-mediated transport of nanoparticles across Caco-2 cells. Int. J. Pharm. 179:1999;247-255.
57. Russell-Jones G.J. Use of vitamin B12 conjugates to deliver protein drugs by the oral route. Crit. Rev. Ther. Drug Carrier Syst. 15:1998;557-586.
58. Sass W., Dreyer H.P., Bockeler W., Hamelmann H., Seifert J. Principles of particle resorption in the gastrointestinal tract. Z. Gastroenterol. 25:1987;306-315.
59. Sass W., Dreyer H.P., Seifert J. Rapid insorption of small particles in the gut. Am. J. Gastroenterol. 85:1990;255-260.
60. Jani P.U., McCarthy D.E., Florence A.T. Nanospheres and microsphere uptake via Peyer's patches: observation of the rate of uptake in the rat after a single oral dose. Int. J. Pharm. 86:1992;239-246.
61. Jani P.U., Florence A.T., McCarthy D.E. Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat. Int. J. Pharm. 84:1992;245-252.
62. Howard K.A., Thomas N.W., Jenkins P.G., Davis S.S., Hagan D.T.O. The absorption of microparticles into Peyer's patches of the rabbit and rat. Pharm. Sci. Com. 4:1994;207-216.
63. Jenkins P.G., Howard K.A., Blackhall N.W., Thomas N.W., Davis S.S., Hagan D.T.O. Microparticulate absorption from the rat intestine. J. Control. Release. 29:1994;339-350.
64. Carr K.E., Hazzard R.A., Reid S., Hodges G.M. The effect of size on uptake of orally administered latex microparticles in the small intestine and transport to mesenteric lymph nodes. Pharm. Res. 13:1996;1205-1209.
65. Desai M.P., Labhasetwar V., Amidon G.L., Levy R.J. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm. Res. 13:1996;1838-1845.
66. Tabata Y., Inoue Y., Ikada Y. Size effect on systemic and mucosal immune response induced by oral administration of biodegradable microspheres. Vaccine. 14:1996;1677-1685.
67. Damgé C., Aprahamian M., Marchais H., Benoit J.P., Pinget M. Intestinal absorption of PLAGA microspheres in the rat. J. Anat. 189:1996;491-501.
68. Eldridge J.H., Hammond C.J., Meulbroek J.A., Staas J.K., Gilley R.M., Tice T.R. Controlled vaccine release in the gut-associated lymphoid tissues. Orally administered biodegradable microspheres target the Peyer's patches. J. Control. Release. 11:1990;205-214.
69. Jepson M.A., Simmons N.L., Hagan D.T.O., Hirst B.H. Comparison of poly(DL-lactide-co-glycolide) and polystyrene microsphere targeting to intestinal M cells. J. Drug Targeting. 1:1993;245-249.
70. Eyles J., Alpar O., Field W.N., Lewis D.A., Keswick M. The transfer of polystyrene microspheres from the gastrointestinal tract to the circulation after oral administration in the rat. J. Pharm. Pharmacol. 47:1995;561-565.
71. Florence A.T., Hillery A.M., Hussain N., Jani P.U. Nanoparticles as carriers for oral peptide absorption: studies on particle uptake and fate. J. Control. Release. 36:1995;39-46.
72. Norris D.A., Puri N., Sinko P.J. The effect of physical barriers and properties on the oral absorption of particulates. Adv. Drug Deliv. Rev. 34:1998;135-154.
73. Hillery A.M., Florence A.T. The effect of adsorbed poloxamer 188 and 407 surfactants on the intestinal uptake of 60-nm polystyrene particles after oral administration in the rat. Int. J. Pharm. 132:1996;123-130.
74. Mathiowitz E., Jacob J.S., Jong Y.S., Carino G.P., Chickering D.E., Chaturvedi P., Santos C.A., Vijayaraghavan K., Montgomery S., Bassett M., Morrell C. Biologically erodable microspheres as potential oral drug delivery systems. Nature. 386:1997;410-414.
75. Nefzger M., Kreuter J., Voges R., Liehl E., Czok R. Distribution and elimination of polymethyl methacrylate nanoparticles after peroral administration to rats. J. Pharm. Sci. 73:1984;1309-1311.
76. Jepson M.A., Simmons N.L., Savidge T.C., James P.S., Hirst B.H. Selective binding and transcytosis of latex microspheres by rabbit intestinal M cells. Cell Tissue Res. 271:1993;399-405.
77. Hillery A.M., Jani P.U., Florence A.T. Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles. J. Drug Targeting. 2:1994;151-156.
78. Jani P.U., McCarthy D.E., Florence A.T. Titanium dioxide (rutile) particle uptake from the rat GI tract and translocation to systemic organs after oral administration. Int. J. Pharm. 105:1994;157-168.
79. Hodges G.M., Carr E.A., Hazzard R.A., Carr K.E. Uptake and translocation of microparticles in small intestine. Morphology and quantification of particle distribution. Dig. Dis. Sci. 40:1995;967-975.
80. Jani P.U., Nomura T., Yamashita F., Takakura Y., Florence A.T., Hashida M. Biliary excretion of polystyrene microspheres with covalently linked FITC fluorescence after oral and parenteral administration to male Wistar rats. J. Drug Targeting. 4:1996;87-93.
81. Eyles J.E., Alpar H., Conway B.R., Keswick M. Oral delivery and fate of Poly(lactic acid) microsphere-encapsulated interferon in rats. J. Pharm. Pharmacol. 49:1997;669-674.
82. Breitenbach A., Kissel T. Biodegradable comb polyesters: Part 1. Synthesis, characterization and structural analysis of poly(lactide) and poly(lactide-co-glycolide) grafted onto water-soluble poly(vinyl alcohol) as backbone. Polymer. 39:1998;3261-3271.
83. Breitenbach A., Jung T., Kamm W., Kissel T. Novel polymeric carriers for oral protein delivery: synthesis and characterization of brush-like PLGA grafted onto hydrophilic polyelectrolyte backbones. Pharm. Sci. Suppl. 1:1998;300.
84. Jung T., Breitenbach A., Kissel T. Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolides) facilitates the preparation of small negatively charged biodegradable nanospheres for protein delivery. J. Control. Release. 1999;. in press.
85. Luessen H.L., de Leeuw B.J., Langemeyer M.W., de Boer A.B., Verhoef J.C., Junginger H.E. Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. Pharm. Res. 13:1996;1668-1672.
86. Bowersock T.L., Hogen-Esch H., Suckow M., Porter R.E., Jackson R., Park H., Park K. Oral vaccination with alginate microsphere systems. J. Control. Release. 39:1996;209-220.
87. Kamm W., Jung T., Breitenbach A., Vogel U., Kaiserling E., Kissel T. Novel PLG-G-PVA nanoparticles for oral protein delivery: intestinal bioadhesion, uptake and cyto-toxicity. Pharm. Sci. Suppl. 1:1998;299-300.
88. Jung T., Kamm W., Breitenbach A., Hungerer K.-D., Hundt E., Kissel T. Oral and nasal administration of Tetanus Toxoid loaded nanoparticles consisting of novel charged biodegradable polyesters for mucosal vaccination. Proc. Int. Symp. Control. Release Bioact. Mater. 26:1999;5021.
89. Norde W. Adsorption of proteins from solution at the solid-liquid interface. Adv. Coloid Interface Sci. 25:1986;267-340.
90. Alpar H.O., Almeida A.J. Identification of some of the physicochemical characteristics of microspheres which influence the induction of the immune response following mucosal delivery. Eur. J. Pharm. Biopharm. 40:1994;198-202.
91. Alpar H.O., Eyles J.E., Williamson E.D. Oral and nasal immunization with microencapsulated clinically relevant proteins. S.T.P. Pharma Sci. 8:1998;31-39.
92. Walker R.I. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine. 12:1994;387-400.